ScholarIQanswers from OpenAlex & ORCID
Rubén Burgos‐Vargas
ResearcherPublications, citations & collaboration network
Rubén Burgos‐Vargas is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Rubén Burgos‐Vargas have?
ScholarIQindexed works
Rubén Burgos‐Vargas has 324 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Rubén Burgos‐Vargas have?
ScholarIQcitation count
Rubén Burgos‐Vargas has 20,325 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Rubén Burgos‐Vargas?
ScholarIQh-index
Rubén Burgos‐Vargas has an h-index of 61 in OpenAlex.
What is the i10-index of Rubén Burgos‐Vargas?
ScholarIQi10-index
Rubén Burgos‐Vargas has an i10-index of 169 in OpenAlex.
What is the ORCID of Rubén Burgos‐Vargas?
ScholarIQorcid
The ORCID for Rubén Burgos‐Vargas is on the source record.
What is the OpenAlex record for Rubén Burgos‐Vargas?
ScholarIQopenalex
The OpenAlex for Rubén Burgos‐Vargas is on the source record.
What are the most-cited papers on Rubén Burgos‐Vargas?
ScholarIQmost cited works
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
Claire Bombardier, Loren Laine, Alise Reicin, Deborah R. Shapiro, Rubén Burgos‐Vargas, Barry R. Davis, Richard O. Day, Marcos Bosi Ferraz, Christopher J. Hawkey, Marc C. Hochberg, Tore K Kvien, Thomas J. Schnitzer
The safety and efficacy of a JAK inhibitor in patients with active rheumatoid arthritis: Results of a double‐blind, placebo‐controlled phase IIa trial of three dosage levels of CP‐690,550 versus placebo
Joel M. Kremer, Bradley J. Bloom, Ferdinand C. Breedveld, John Coombs, Mark P. Fletcher, David Gruben, Sriram Krishnaswami, Rubén Burgos‐Vargas, Bethanie Wilkinson, Cristiano A. F. Zerbini, Samuel H. Zwillich
Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structu
Joel M. Kremer, Ricardo Blanco, Marek Brzosko, Rubén Burgos‐Vargas, Anne-Marie Halland, Emma Vernon, Petra Ambs, Roy Fleischmann